Technological survey on LIMS and ELN in Life Sciences - Biogenouest

More documents

Recommendations

Info

The first ELN solution was developed in the 1990s. 2 types of ELN are currently onthe market:- Generic ELN: not dedicated to any discipline/application and adapted to fullenterprise deployment- Specific ELN: developed for a particular discipline or application, adapted todepartment-wide deploymentThe main asset of ELN is its regulatory and legal compliance. ELN is expected tocomply with FDA regulations related to software protection (electronic signature forexample) and is often referred to patent prosecution and IP litigation.LIMS is designed to store data (sample management, instrument and applicationintegration, electronic data exchange and more) and is useful for operational entitiesin the laboratory to manage samples and sample flow management (see Figure 3).Stock management CertiSicate reports Samples Complaint management Quality management Equipment connections Dashboard Data Slow management Figure 3 – LIMS applicationsThe first LIMS solution appeared in the 1970s and the first commercial solution waslaunched in 1982.2 types of LIMS are currently on the market:- Commercial (license based solutions)- OpenSource (free access solutions designed by web communities)LIMS have multiple uses in quality control/quality assurance (QA/QC),manufacturing, R&D laboratories, workflow and data tracking support. Compared toELN, LIMS is highly configurable and scalable (well adapted for research in genomicand genetic laboratories for example) with a flexible architecture and smart dataexchange interfaces.8
The implementation of data management solutions in the Life Science environment iscomplicated. The work plan/architecture and solution strategy will be differentaccording to the type of activity: industry, academic or solution provider (such asCRO for pharmaceutical industry), therefore making it difficult to provide a commongeneric solution.Before implementing a data management solution, the aims and objectives must bewell specified to ensure that the solution will match the specific needs. Theevaluation and routine use of LIMS and ELN cannot be implemented before settlingthe strategy.As a matter of fact, designing the right product requires accessing, integrating,storing and analyzing a vast amount of data. Everything from complex scientific datafor drugs, chemicals and materials is connected to the associated informationneeded to bring the product successfully to market. Without an efficient datamanagement solution the innovation process can easily slow down, delaying itsimplementation and the associated benefits.2 -‐ The data management market Analytical Life ScienceInstrumentation$40 bLab. AutomationAnalytical Science$2,8 b$37,2 bLIMS, ELN, 439,6 4,7% SDMS Figure 4 – The Life Science instrumentation market with detailed Lab. Automation9
Page 1 and 2: Technological <str
Page 3 and 4: ) Implemented quality standards
Page 5 and 6: Survey background 1 -‐ Backg
Page 7: Computer data management system
Page 11 and 12: While the vast majority of companie
Page 13 and 14: Figure 7 - LIMS and ELN solutions13
Page 15 and 16: Usage of ELN and LIMS also depends
Page 17 and 18: - Head of platform- Head of resourc
Page 19 and 20: - Need for innovation- Design of ne
Page 21 and 22: ) Implemented quality standards
Page 23 and 24: Nb. of respondents (N=30)3025201510
Page 25 and 26: The perceived benefits of implement
Page 27 and 28: Nb. of respondents (N=17)Surveyed r
Page 29 and 30: As indicated by the suppliers, the
Page 31 and 32: 2 -‐ Quality system The <str
Page 33 and 34: customized solutions since they are
Page 35 and 36: Appendix 1: Online surve
Page 37 and 38: □□□□Pas de besoin actuellem
Page 39 and 40: □□□□□Avantage concurrenti
Page 49 and 50: Appendix 3: Surveyed contact li
Page 51 and 52: Appendix 4: Peer recommendations
Page 53: B$: Billion DollarsCRO: Contract Re

Technological survey on LIMS and ELN in Life Sciences - Biogenouest

Create successful ePaper yourself

Delete template?

Save as template?